← Back to Search

Focus Group for Endometrial Cancer

Phase 1

Waitlist Available

Led By Mark E Sherman

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 months

Awards & highlights

Study Summary

This trial is testing a new way to detect endometrial cancer using DNA from a tampon. Researchers hope this will be a less invasive and painful test, and that it will help reduce racial disparities in death rates from the disease.

Eligible Conditions

Endometrial Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Detection of EC-specific methylation markers (Aim 2)

Differences in views on endometrial cancer (EC) risk between African American and white women and whether the former would be willing to participate in tampon testing (Aim 1)

Endometrial DNA (Aim 2)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Aim 2 (vaginal kit)Experimental Treatment2 Interventions

Participants receive a tampon kit for collection of vaginal samples.

Group II: Aim 1 (focus group)Experimental Treatment2 Interventions

Participants attend a focus group over 2 hours about endometrial cancer including knowledge of abnormal uterine bleeding, post-menopausal bleeding, risk factors, sources of medical information, barriers to seeking gynecologic care, and acceptance of tampon self-collection for endometrial cancer detection.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biospecimen Collection

2004

Completed Phase 2

~1730

Focus Group

2017

Completed Phase 1

~4060

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,205 Previous Clinical Trials

3,766,751 Total Patients Enrolled

5 Trials studying Endometrial Cancer

4,702 Patients Enrolled for Endometrial Cancer

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,120 Total Patients Enrolled

75 Trials studying Endometrial Cancer

73,374 Patients Enrolled for Endometrial Cancer

Mark E ShermanPrincipal InvestigatorMayo Clinic

1 Previous Clinical Trials

191 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the limit for enrolment in this medical experiment?

"Absolutely. Clinicaltrials.gov reveals that the trial, which was inaugurated on February 1st 2020, is currently in search of participants. A total of 110 individuals are expected to be enrolled at a single site."

Answered by AI

Has Focus Group received regulatory approval from the Food and Drug Administration?

"The safety of Focus Group is estimated to be a 1, as it is currently undergoing Phase 1 trials and has only limited evidence supporting its efficacy."

Answered by AI

Are there any openings available for prospective participants in this research project?

"Affirmative. According to the clinicaltrials.gov registry, this medical study is currently recruiting and was first posted on February 1st 2020. It has since been updated on May 17th 2022 with the goal of finding 110 participants from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

2020. "Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04474184.